Clinical Trials Browser

Phase 1 × Immunoglobulins, Intravenous × Plasma cell × Clear all

NCT04634435 2025-01-20

Autologous Memory-like NK Cell Therapy With BHV-1100 and Low Dose IL-2 in Multiple Myeloma Patients

Phase 1 Completed

Other hematologic neoplasmPlasma cell

Multiple Myeloma, Hematologic Neoplasms